The authors report on a 19-year-old woman with systemic sclerosis who underwent CD34+-selected autologous hematopoietic stem-cell transplantation in March 2001. The dermal sclerosis improved immediately after transplantation, but thrombocytopenia and Graves' disease developed.
No takes yet. Share an insight, caveat, or question.
Bohgaki et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: